<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>circulating tumor DNA testing &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/circulating-tumor-dna-testing/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 13:23:12 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>circulating tumor DNA testing &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Revolutionizing Breast Cancer Treatment: The Role of Liquid Biopsy</title>
		<link>https://bioengineer.org/revolutionizing-breast-cancer-treatment-the-role-of-liquid-biopsy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 18 Feb 2025 18:15:06 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[circulating tumor DNA testing]]></category>
		<category><![CDATA[genetic mutations in breast cancer]]></category>
		<category><![CDATA[Liquid biopsy technology]]></category>
		<category><![CDATA[Non-invasive cancer diagnostics]]></category>
		<category><![CDATA[Precision oncology advancements]]></category>
		<guid isPermaLink="false">https://bioengineer.org/revolutionizing-breast-cancer-treatment-the-role-of-liquid-biopsy/</guid>

					<description><![CDATA[A groundbreaking study on circulating tumor DNA (ctDNA) testing for patients suffering from advanced breast cancer has emerged, yielding significant findings that may transform the landscape of oncology treatment. This research underscores the pivotal role of ctDNA as a non-invasive means to detect genetic mutations that can influence treatment decisions, thereby enhancing the precision of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">236334</post-id>	</item>
	</channel>
</rss>
